PeptideDB

CAY10614 1202208-36-3

CAY10614 1202208-36-3

CAS No.: 1202208-36-3

CAY10614 is a potent TLR4 antagonist. CAY10614 inhibits lipid A-induced TLR4 activation with IC50 of 1.675 μM. CAY10614
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

CAY10614 is a potent TLR4 antagonist. CAY10614 inhibits lipid A-induced TLR4 activation with IC50 of 1.675 μM. CAY10614 improves survival in a mouse model of lethal endotoxic shock.

Physicochemical Properties


Molecular Formula C42H78INO2
Molecular Weight 755.98
Exact Mass 755.507
CAS # 1202208-36-3
PubChem CID 25223004
Appearance White to off-white solid powder
LogP 10.369
Hydrogen Bond Donor Count 0
Hydrogen Bond Acceptor Count 3
Rotatable Bond Count 31
Heavy Atom Count 46
Complexity 630
Defined Atom Stereocenter Count 0
InChi Key UXOPVNPWTUWUEA-UHFFFAOYSA-M
InChi Code

InChI=1S/C42H78NO2.HI/c1-5-7-9-11-13-15-17-19-21-23-25-29-35-44-41-34-33-39(38-43(3,4)40-31-27-28-32-40)37-42(41)45-36-30-26-24-22-20-18-16-14-12-10-8-6-2;/h33-34,37,40H,5-32,35-36,38H2,1-4H3;1H/q+1;/p-1
Chemical Name

cyclopentyl-[[3,4-di(tetradecoxy)phenyl]methyl]-dimethylazanium;iodide
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Note: Please store this product in a sealed and protected environment, avoid exposure to moisture.
Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


Targets TLR4 1.675 μM (IC50, in HEK293 cells)
ln Vitro In HEK293 cells, lipid A-induced increases in phosphatase activity are inhibited in a concentration-dependent manner by CAY10614 (Compound 7) (1–10 μM) [1]. In neurons cultured for more than 18 days in vitro (DIV), CAY10614 (0.5 μM) suppresses the rise in [Ca2+]cyt brought on by LPS [2].
ln Vivo Mice given intraperitoneal LPS (20 mg/kg) had considerably higher survival rates when CAY10614 (Compound 7) (10 mg/kg; intraperitoneally injected 30 minutes before LPS) is administered[1].
Animal Protocol Animal/Disease Models: C57BL/6J male mice (9 weeks) were ip injected with 20 mg/kg LPS[1]
Doses: 10 mg/kg
Route of Administration: Ip 30 min before the LPS
Experimental Results: Increased the survival rate of mice from 0% to 67%.
References

[1]. Glycolipids and benzylammonium lipids as novel antisepsis agents: synthesis and biological characterization. J Med Chem. 2009 Feb 26;52(4):1209-13.

[2]. Aging and amyloid β oligomers enhance TLR4 expression, LPS-induced Ca 2+ responses, and neuron cell death in cultured rat hippocampal neurons. J Neuroinflammation. 2017 Jan 31;14(1):24.


Solubility Data


Solubility (In Vitro) DMSO: 12.5 mg/mL (16.53 mM)
Solubility (In Vivo) Solubility in Formulation 1: 0.83 mg/mL (1.10 mM) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), suspension solution; with sonication.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 8.3 mg/mL clear DMSO stock solution to 400 μL of PEG300 and mix evenly; then add 50 μL of Tween-80 to the above solution and mix evenly; then add 450 μL of normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

Solubility in Formulation 2: 0.83 mg/mL (1.10 mM) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), suspension solution; with ultrasonication.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 8.3 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 1.3228 mL 6.6139 mL 13.2279 mL
5 mM 0.2646 mL 1.3228 mL 2.6456 mL
10 mM 0.1323 mL 0.6614 mL 1.3228 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.